<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80-viruses-12-00518">
 <label>80.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chung</surname>
    <given-names>K.Y.</given-names>
   </name>
   <name>
    <surname>Coyle</surname>
    <given-names>E.M.</given-names>
   </name>
   <name>
    <surname>Jani</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>King</surname>
    <given-names>L.R.</given-names>
   </name>
   <name>
    <surname>Bhardwaj</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Fries</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Glenn</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Golding</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Khurana</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>ISCOMATRIX adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans</article-title>
  <source>Vaccine</source>
  <year>2015</year>
  <volume>33</volume>
  <fpage>3953</fpage>
  <lpage>3962</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.06.047</pub-id>
  <pub-id pub-id-type="pmid">26093202</pub-id>
 </element-citation>
</ref>
